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Abstract
This brief paper highlights the EU/US Gendered Innovations (GI) 
Project which aims to develop methods of sex and gender analysis for 
research. A total of 21 case studies from a broad range of scientific 
fields offer concrete illustrations of how sex and gender analysis leads 
to new ideas and excellence in research . Two case studies are described 
to some extent: stem cell research and an example on the increase in 
non-communicable diseases from the field of nutrigenomics. The peer-
reviewed full case studies, including all references can be found at the 
GI website. In Horizon 2020 “Gender will be addressed as a cross-cutting 
issue in order to rectify imbalances between women and men, and to 
integrate a gender dimension in research and innovation programming 
and content”. Applicants are referred to the GI materials as a resource 
for those topics flagged for gender relevance.  
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Educational aims
•	 To encourage analysis sex and gender in biomedical research
•	 To highlight the need of biomedical researchers for practical tools in sex and gender 
analysis, such as those provided by the Gendered Innovations Project
•	 To emphasise that integrating sex and gender analysis (together with intersecting 
factors) provides excellence in research and sparks new knowledge
Introduction
Research addressing sex and gender in 
biomedical sciences and clinical medicine 
is emerging as a promising field. ‘Gender 
Medicine’ (GM) is increasing the evidence 
on differences between women and men in 
pathophysiology and manifestation of many 
diseases and in received health care.  There is 
an increasing recognition that both sex and 
gender affect the health of women and men. 
Sex refers to biological differences between 
women and men: genetic predisposition to 
diseases, body size and composition, drug 
metabolism. Gender refers to cultural and 
social attitudes that together shape “feminine” 
and “masculine” behaviour. Humans function 
in large and complex societies through learned 
behaviours. Gender is one aspect of these 
sets of behaviours and therefore gender based 
attitudes influence health. GM duly recognizes 
that sex and gender (S&G) influence each other 
and are inseparable in their relation to human 
diseases. Shorter life span and myocardial 
infarctions at younger age in men may be 
due to biological causes, such as a recently 
discovered gene variant on the Y-chromosome, 
but may also be related to stress or risk taking 
behaviours. Vice versa, gender based life style 
factors, smoking, toxins, nutrition and exercise 
modify DNA packaging and gene transcription 
by epigenetic mechanisms and thereby alter 
body composition. Adverse drug effects cause 
a large number of medical complications 
particularly in women which may be due to sex 
differences in drug metabolism as well as to 
gender related differences in prescription and 
drug use. Interaction of sex and gender related 
mechanisms leads to different manifestation 
of frequent diseases such as infarction, heart 
failure, diabetes, rheumatic disease and also 
infections in women and men.1-6 
Innovations through gender
Given the wealth of evidence as described 
above it has become a matter of urgency 
to provide the research community with 
appropriate tools to address sex and gender 
in their research. In 2011 the European 
Commission established the expert group 
‘Innovation through Gender’ directed by Londa 
Schiebinger and Ineke Klinge to develop 
the much needed materials. A Gendered 
Innovations website had already been started 
at Stanford University by Londa Schiebinger 
in 2009. The initiated EU/US project Gendered 
Innovations in Science, Health & Medicine, 
Engineering and Environment can be seen as 
following up on earlier EU framework projects 
addressing the gender dimension of the 
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research content, representing a translation of  
the EU gender mainstreaming policy to research 
policy.7,8  
Identifying gender bias and understanding 
how it operates in science and technology is 
important.  But analysis cannot stop there: 
designing sex and gender analysis into research 
stimulates new knowledge and technologies. 
From the start, sex and gender analyses act 
as additional “controls” (or filters for bias) 
to provide excellence in science, health and 
medicine, and engineering research, policy, and 
practice.9 
Gendered Innovations 2011-2013
To achieve these goals, the Gendered 
Innovations (GI) 2011-2013 project aimed 
at providing researchers with the tools to 
integrate sex and gender analysis in their 
research design. In seven international 
collaborative workshops, held in Europe and the 
US, materials have been developed and peer 
reviewed by 57 experts from different scientific 
fields (see contributors on the website) 
together with gender experts. The website 
portals contain the following materials:
•	 Methods of sex and gender analysis relevant 
to science, health & medicine, engineering 
and environment
•	 Terminology defining key concepts used 
throughout the site; 
•	 Case Studies documenting specific gendered 
innovations and demonstrating how 
methods of sex and gender analysis are 
applied in specific examples.
•	 The final report Gendered Innovations. How 
gender analysis contributes to research 
was presented in a special session in 
the European Parliament in July 2013 
together with the final smart website 
available at: http://ec.europa.eu/research/
science-society/gendered-innovations/
index_en.cfm.10
On adopting the Horizon 2020 programme 
for research and innovation the EC has 
formulated an important article (#15) in which 
it reaffirms its commitment to integrate sex 
and gender analysis into research.11 Applicants 
for projects under Horizon 2020 are directed 
to the GI website materials when a particular 
topic across various fields has been ‘flagged’ to 
consider the relevance of incorporating a sex 
and gender analysis.
GI narratives
The two GI narratives below are an illustration 
of the new knowledge that can be created by 
integrating a sex and gender analysis.  
 
Stem cell research
Between 1997 and 2000 ten drugs were 
withdrawn from the U.S. market because of life-
threatening health effects; eight of these posed 
greater threats for women. Not only did these 
drugs cost billions of Euros to develop - but 
when they failed, they caused death and human 
suffering. There are many reasons why drugs fail 
- and they fail more often for women.  
Most research is done in males, whether 
human or animal, and the sex of cells and 
tissues is often not taken into account. 12,13 This 
has serious implications. for example, in stem 
cell research, a highly valued area of research. 
Stem cell research holds promises for treating 
debilitating diseases, such as Parkinson’s 
disease and muscular dystrophy. Stem cell 
research focuses on inducing pluripotency in 
cells derived from adults and using these cells 
to repair or reconstruct organs. Yet, in most 
labs, the sex of the cells is not taken into 
account, which can lead to life-threatening 
consequences and leave researchers with 
unsolved puzzles. Take for example the problems 
an international collaboration between labs in 
Norway and Australia encountered working with 
bone marrow stem cells in mice. Researchers 
in the labs appropriately used both male 
and female mice, but they used all female 
stem cells without considering why. This was 
an unconscious decision and the result was 
that their male mice died - and they did not 
understand why. 
Some answers to this problem are given on 
the Gendered Innovations website - and they 
are real eye openers: importantly, taking sex 
into account can advance basic knowledge. 
Research has documented potential sex 
differences in the therapeutic capacity (such as 
proliferation and differentiation) of stem cells 
as well as sex differences in receptor-mediated 
pathways. For example: muscle-derived stem 
cells have the capacity to repair heart muscle 
tissues as well as skeletal muscle tissues. 
Researchers found that XX cells, showed a 
higher regenerative capacity than XY cells. This 
constitutes an important therapeutic finding. Of 
course there are other variables besides sex at 
play, such as the type of stem cell being used, 
type of disease being treated, and hormonal and 
environmental factors plus their interactions. 
But we cannot neglect the sex of cells. So what 
happened with the Norwegian and Australian 
labs?  Once they considered all combinations 
of sex in donor/recipient interaction, they 
had greater success with their experiments. 
The GI method: Analyzing Sex summarizes 
the important steps - the key message is that 
researchers report the sex of cells and consider 
the sex of both the donor and recipient in their 
research. 
Nutrigenomics 
A second story comes from the field of 
nutrigenomics - an important area for public 
health - and a priority for Horizon 2020.
The epidemic of non-communicable diseases 
- heart disease, diabetes and cancers - is on the 
rise across Europe and North America.  These 
diseases are caused by risk factors such as 
unhealthy diets, lack of exercise and smoking 
tobacco, and can be eradicated through smart 
research and policy. To develop excellent 
research in this area, we need to understand 
how sex and gender (plus income and other 
social factors) influence these risk factors
Fig 1 shows the relative influences of 
sex- and gender-related factors determining a 
Figure 1: Cumulative life course risk factors for non-communicable disease (NCD)
Highlighting the influence of sex and gender-related factors
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person’s risk for non-communicable diseases 
over her or his lifetime.  Importantly both 
gender-related social factors and sex-related 
biological factors interact from the time you 
are in the womb to determine how well you 
age. Obesity (a risk factor for diabetes) is an 
example where gender analysis is important. 
To understand differences in women’s and 
men’s obesity rates, we need to analyse gender 
differences in lifestyle.  Perhaps gender norms 
in society lead men to exercise more than 
women; this can lead to greater disease among 
women. And perhaps gender norms in society 
lead men to eat less healthy food than women. 
This gendered behavior can lead to greater 
disease among men. 
So gender behaviors can influence health. 
And so can biological sex. Analyzing sex is 
important too in the field of nutrigenomics. 
Figure 2 shows how gender-related food 
intake is translated into sex-specific basic 
metabolism, gene expression, and, finally, into 
the response to diets. Nutrigenomicists have 
used sex analysis to explore - at the functional, 
mechanistic level - how nutrients affect gene 
expression and cell function in women and 
men. In one study, they examined vitamin 
E gene interactions affecting the incidence 
of respiratory tract infections in the elderly. 
The main finding suggested that the effect of 
vitamin E depended on sex: only in women - 
with a certain genotype - did vitamin E reduce 
respiratory tract infections.
Finally some more examples of Gendered 
Innovations in summary: 
1. Sex analysis has revealed that the 
pathophysiology of CVD is different in 
Figure 2: Gendered model for analyzing mechanisms involved in food intake and processing
Key points
By employing sex and gender analysis as a resource to create new knowledge and 
technology researchers can: 
•	 add value to research and engineering by ensuring excellence in outcomes 
•	 add value to society by making research more responsible to social needs 
•	 add value to business by developing new ideas, patents and technology.
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Contributors). 
Further Reading
•	 Sex	and	Gender	Differences	in	Pharmacology.	
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men and women especially in younger 
women. It has led to better diagnostic 
techniques and symptomatology. Analyzing 
gender assumptions has improved 
the understanding of risk factors and 
prevention. 
2. The inclusion of men in osteoporosis 
research has led to better diagnoses and 
treatments. In the past, osteoporosis 
was conceptualized as a disease of 
postmenopausal women.
3. Sex analysis in animal research has led to 
new knowledge about how sex hormones 
influence basic molecular pathways 
involved in immune system function.14
Conclusion
Integrating sex and gender analysis into all 
phases of research has been shown to spark 
creativity by offering new perspectives, posing 
new questions  and opening new areas to 
research. Sex and gender analysis enhances 
excellence in research and will make research 
responsive to the needs of the whole society, 
both women and men.
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